GILD - Gilead Sciences opportunity

Today morning the EU commission announced that it has signed a purchasing agreement of 500.000 treatments of Veklury(the brand name for Remdesivir).

I think this will have an impact on the GILD stock price.

As always please don’t listen to anyone on the internet and do your own research.

Happy investing.

1 Like